Request a copy

Full Text

4

CITATIONS

4 Total citations

1 Recent citation

0.55 Field Citation Ratio

0.22 Relative Citation Ratio

publications

0

supporting

0

mentioning

0

contrasting

0

Smart Citations

0

0

0

0

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

• Ceusters J.D., Serteyn D.A., Minguet G., de la Rebière de Pouyade G., Romainville J., Deby-Dupont G.P., Mouithys-Mickalad A.A., Franck T.J. An in vitro whole blood model to test the effects of different stimuli conditions on the release of myeloperoxidase and elastase by equine neutrophils. Vet. Immunol. Immunopathol. 2012, 150:221-227.
• Davies M.J., Hawkins C.L., Pattison D.I., Rees M.D. Mammalian heme peroxidases: from molecular mechanisms to health implications. Antioxid. Redox Signal. 2008, 10:1199-1234.
• Deby-Dupont G., Deby C., Lamy M. Neutrophil myeloperoxidase revisited: its role in health and disease. Intensivmed. Notfallmed. 1999, 36:500-513.
• de la Rebiere G., Franck T., Deby-Dupont G., Salciccia A., Grulke S., Péters F., Serteyn D. Effects of unfractionated and fractionated heparins on myeloperoxidase activity and interactions with endothelial cells: possible effects on the pathophysiology of equine laminitis. Vet. J. 2008, 178:62-69.
• Eckenhoff R.G., Johansson J.S. Molecular interactions between inhaled anesthetics and proteins. Pharmacol. Rev. 1997, 49:343-367.
• Franck T., Grulke S., Deby-Dupont G., Deby C., Duvivier H., Peters F., Serteyn D. Development of an enzyme-linked immunosorbent assay for specific equine neutrophil myeloperoxidase measurement in blood. J. Vet. Diagn. Invest. 2005, 17:412-419.
• Franck T., Kohnen S., Deby-Dupont G., Grülke S., Deby C., Serteyn D. A specific method for measurement of equine active myeloperoxidase in biological samples and in in vitro tests. J. Vet. Diagn. Invest. 2006, 18:326-334.
• Franck T., Kohnen S., Grulke S., Neven P., Goutman Y., Peters F., Pirotte B., Deby-Dupont G., Serteyn D. Inhibitory effect of curcuminoids and tetrahydrocurcuminoids on equine activated neutrophils and myeloperoxidase activity. Physiol. Res. 2008, 57:577-587.
• Fröhlich D., Rothe G., Schwall B., Schmid P., Schmitz G., Taeger K., Hobbhahn J. Effects of volatile anaesthetics on human neutrophil oxidative response to the bacterial peptide FMLP. Br. J. Anaesth. 1997, 78:718-723.
• Grulke S., Franck T., Gangl M., Péters F., Salciccia A., Deby-Dupont G., Serteyn D. Myeloperoxidase assay in plasma and peritoneal fluid of horses with gastrointestinal disease. Can. J. Vet. Res. 2008, 72:37-42.
• Hu G., Salem M.R., Crystal G.J. Role of adenosine receptors in volatile anesthetic preconditioning against neutrophil-induced contractile dysfunction in isolated rat hearts. Anesthesiology 2005, 103:287-295.
• Klebanoff S.J. Myeloperoxidase: friend and foe. J. Leukoc. Biol. 2005, 77:598-625.
• Kohnen S., Franck T., Van Antwerpen P., Boudjeltia K.Z., Mouithys-Mickalad A., Deby C., Moguilevsky N., Deby-Dupont G., Lamy M., Serteyn D. Resveratrol inhibits the activity of equine neutrophil myeloperoxidase by a direct interaction with the enzyme. J. Agric. Food Chem. 2007, 55:8080-8087.
• Le Y., Murphy P.M., Wang J.M. Formyl-peptide receptors revisited. Trends Immunol. 2002, 23:541-548.
• Malle E., Furtmüller P.G., Sattler W., Obinger C. Myeloperoxidase: a target for new drug development?. Br. J. Pharmacol. 2007, 152:838-854.
• Minguet G., de la Rebière G., Franck T., Joris J., Serteyn D., Sandersen C. Sevoflurane inhibits equine myeloperoxidase release and activity in vitro. Vet. Anaesth. Analg. 2013, 40:166-175.
• Nakagawara M., Takeshige K., Takamatsu J., Takahashi S., Yoshitake J., Minakami S. Inhibition of superoxide production and Ca2+ mobilization in human neutrophils by halothane, enflurane, and isoflurane. Anesthesiology 1986, 64:4-12.
• Saad M.M., Eom W., Hu G., Kim S.J., Crystal G.J. Persistency and pathway of isoflurane-induced inhibition of superoxide production by neutrophils. Can. J. Anaesth. 2010, 57:50-57.
• Serteyn D., Sandersen C., Lejeune J.P., de la Rebière de Pouyade G., Ceusters J., Mouithys-Mickalad A., Niesten A., Fraipont A., van Erck E., Goachet A.G., Robert C., Leclerc J.L., Votion D.M., Franck T. Effect of a 120km endurance race on plasma and muscular neutrophil elastase and myeloperoxidase concentrations in horses. Equine Vet. J. 2010, 38(Suppl.):275-279.
• Strum D.P., Eger E.I. Partition coefficients for sevoflurane in human blood, saline, and olive oil. Anesth. Analg. 1987, 66:654-656.
• Tay S.P., Cheong S.K., Hamidah N.H., Ainoon O. Flow cytometric analysis of intracellular myeloperoxidase distinguishes lymphocytes, monocytes and granulocytes. Malays. J. Pathol. 1998, 20:91-94.
• Urner M., Limbach L.K., Herrmann I.K., Müller-Edenborn B., Roth-Z'Graggen B., Schlicker A., Reyes L., Booy C., Hasler M., Stark W.J., Beck-Schimmer B. Fluorinated groups mediate the immunomodulatory effects of volatile anesthetics in acute cell injury. Am. J. Respir. Cell Mol. Biol. 2011, 45:617-624.
• Yuki K., Astrof N.S., Bracken C., Yoo R., Silkworth W., Soriano S.G., Shimaoka M. The volatile anesthetic isoflurane perturbs conformational activation of integrin LFA-1 by binding to the allosteric regulatory cavity. FASEB J. 2008, 22:4109-4116.
• Yuki K., Astrof N.S., Bracken C., Soriano S.G., Shimaoka M. Sevoflurane binds and allosterically blocks integrin lymphocyte function-associated antigen-1. Anesthesiology 2010, 113:600-609.